Evidence-based selection criteria to protect blood donors

Journal of Clinical Apheresis

Volumn 25, Issue 6, 2010, Pages 331-337

  Eder, Anne ^a  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

blood donors; blood pressure; hemoglobin

Indexed keywords

HEMOGLOBIN;

ARTICLE; BLOOD DONOR; BLOOD PRESSURE; BLOOD TRANSFUSION; BLOOD VOLUME; BODY WEIGHT; DONOR SELECTION; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; PULSE RATE; RED CROSS;

BLOOD DONORS; BLOOD PRESSURE; BODY WEIGHT; DONOR SELECTION; EVIDENCE-BASED PRACTICE; HEMOGLOBINS; HUMANS; PATIENT SELECTION; PULSE;

EID: 78650092233     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20257     Document Type: Article

References (34)

1. Eder A, Goldman M, Rossmann S, Waxman D, Bianco C,. Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance). Transfus Med Rev 2009; 23: 205-220.
2. Eder AF, Dy BA, Kennedy J, Notari E, Strupp A, Wissel ME, Reddy R, Gibble J, Haimowitz MD, Newman BH, Chambers LA, Hillyer CD, Benjamin RJ,. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006. Transfusion 2008; 48: 1809-1819.
3. Department of Health and Human Services, Food and Drug Administration, Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use. Proposed Rule Federal Register: November 8, 2007 (Volume 72, Number 216) 21 CFR Parts 606, 610. Available at:; Accessed July 31, 2010.
4. Price TH,. AABB Standards for Blood Banks and Transfusion Services, 26th ed. Bethesda, MD: AABB; 2009.
5. Council of Europe. Guide to the preparation, use and quality assurance of blood components. 14th ed. 2008. ISBN 978-92-871-5667-9.
6. Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. Official Journal of the European Union. Available at:; Accessed July 31, 2010.
7. Caffrey E,. Blood matters: quarterly information for hospitals served by the National Blood Service (newsletter). 2006; 19: 3-4. Available at:; Accessed July 31, 2010.
8. Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S,. Trends in hypertension prevalence, awareness, treatment, and control in older adults: data from the National Health and Nutrition Examination Survey 1988-2004. J Am Geriatrics Soc 2007; 55: 1056-1065.
9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ,. National Heart Lunch and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report JAMA 2003; 289: 2560-2570.
10. Food and Drug Administration Blood Products Advisory Committee. November 17, 2009 Topic III: Blood Pressure and Pulse as Eligibility Criteria. Available at:. Accessed July 6, 2010.
11. Wiltbank TB, Giordano GF, Kamel H, Tomasulo P, Custer B,. Faint and prefaint reactions in whole-blood donors: an analysis of predonation measurement and their predictive value. Transfusion 2008; 48: 1799-1808.
12. Trouern-Trend JJ, Cable RG, Badon SJ, Newman BH, Popovsky MA,. A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse. Transfusion 1999; 39: 316-320.
13. Goldman M, Fournier E, Cameron-Choi K, Steed T,. Effect of changing the age criteria for blood donors. Vox Sang 2007; 92: 368-372.
14. Newman B, Siegried B, Haley NR, Feller I, Sledge L, Roth A,. Quantitative study of contributing factors to vasovagal donor reaction rates in eight blood centers (abstract). Transfusion 2008; 48 (Suppl 2): 58A.
15. Eder AF, Hillyer CD, Dy BA, Notari EP, Benjamin RJ,. Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA 2008; 299: 2279-2286.
16. Kamel H, Custer B, Bravo M, Tomasulo P,. Do multiple interventions to reduce adverse reactions in young female donors lower rates of reaction? A preliminary analysis. Transfusion 2009; 49 (Suppl): 3A.
17. Eder AF, Dy BA, Kennedy JM, Demaris P, Procaccio A, Benjamin RJ,. Improved safety for young whole blood donors with new selection criteria for total blood volume. Transfusion, in press.
18. Rios JA, Fang J, Tu Y, Wright DJ, Spencer B, Hillyer CD, Hillyer KL, Eder AF, Benjamin RJ,. The potential impact of selective donor deferrals based on estimated blood volume on vasovagal reactions and donor deferral rates. Transfusion 2010; 50: 1265-1275.
19. Bonk VA, France CR, Taylor BK,. Distraction reduces self-reported physiological reactions to blood donation in novice donors with a blunting coping style. Psychosom Med 2001; 63: 447-452.
20. France CR, France JL, Kowalsky JM, Cornett TL,. Education in donation coping strategies encourages individuals to give blood: further evaluation of a donor recruitment brochure. Transfusion 2010; 50: 85-91.
21. Newman B, Tommolino E, Andreozzi C, Joychan S, Pocedic J, Heringhausen J,. The effect of a 473-mL (16-oz) water drink on vasovagal donor reaction rates in high-school students. Transfusion 2007; 47: 1524-1533.
22. France CR, Ditto B, Wissel ME, France JL, Dickert T, Rader A, Sinclair K, McGlone S, Trost Z, Matson E,. Predonation hydration and applied muscle tension combine to reduce presyncopal reactions to blood donation. Transfusion 2010; 50: 1257-1264.
23. Simon TL,. Iron, iron everywhere but not enough to donate. Transfusion 2002; 42: 664-665.
24. Bianco C, Brittenham G, Gilcher RO, Gordeuk VR, Kushner JP, Sayers M, Chambers L, Counts RB, Aylesworth C, Nemo G, Alving B,. Maintaining iron balance in women blood donors of childbearing ages: summary of a workshop. Transfusion 2002; 42: 798-805.
25. Food and Drug Administration Blood Products Advisory Committee. Iron status in blood donors, slides of committee presentations. Rockville, MD: CBER Office of Communication, Training and Manufacturers Assistance, 2008. Available at:.
26. Cable RG,. Hemoglobin determination in blood donors. Transfus Med Rev 1995; 9: 131-144.
27. Beutler E, Waalen J,. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006; 107: 1747-1750.
28. Boulton F,. Managing donors and iron deficiency. Vox Sang 2004; 87 (Suppl 2): S22-S24.
29. Fowler WM, Barer AP,. Rate of hemoglobin regeneration in blood donors. JAMA 1942; 118: 421.
30. Simon T, Garry PJ, Hooper EM,. Iron stores in blood donors. J Am Med Assn 1981; 245: 2038-2043.
31. Keller AJ, Goldman M,. Hemoglobin measurement and iron status of blood donors. In:, Eder A, Goldman M, editors. Blood Donor Health and Safety. Bethesda, MD: AABB Press; 2010. pp 21-37.
32. Alvarez-Ossorio L, Kirchner H, Kluter H, Schlenke P,. Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron depletion in regular blood donors. Transf Med 2000; 10: 107-112.
33. Mast AE, Schlumpf KS, Wright DJ, Custer B, Spencer B, Murphy EL, Simon TL,; for the NHLBI Retrovirus Epidemiology Donor Study-II. Demographic correlates of low hemoblogin deferral among prospective whole blood donors. Transfusion, in press.
34. Custer B, Chinn A, Hirschler NV, Busch MP, Murphy EL,. The consequences of temporary deferral on future whole blood donation. Transfusion 2007; 47: 1514-1523.